Press "Enter" to skip to content

BudTrader.com™ passes 250,000 + registered users

San Diego, CA – January 1, 2017 — Free classified website BudTrader.com announced Wednesday that it is long gone 250,000 new users. BudTrader™ reports it is adding around 1000+ registered users each day. BudTrader™ recently began earning cash in July and our reported revenue over $120,000 for 2016. BudTrader™ offers users an opportunity to cover to acquire their ad re-posted daily as well as to stay at the top of the first page and highlighted. “BudTrader™ is joining together the medical marijuana community. Patients, growers and dispensaries are in possession of a safe and secure and fair destination to advertise or acquire their medical marijuana,” says Brad McLaughlin CEO.


BudTrader™ has been actively advocating Medicinal marijuana usage of patients and recreational legalization in over the dozen states.“There happen to be numerous studies that relate the major health improvements from patients using medical marijuana/CBD. BudTrader™ believes that no patient needs to be denied usage of medical marijuana, it doesn’t matter what state they are in,” says McLaughlin. With medical/recreational marijuana on the ballot in 9 states, McLaughlin is predicting a ‘Green Rush’. “You’re gonna view a a lot of extra people entering the area. Not only individual entrepreneurs, but banks, large corporations and Wall Street. There’ll be a lot of opportunity from the space the next 3 to 5 years.”

BudTrader.com™ is a safety for dabs patients and clubs in promoting their goods and services. BudTrader™ is joining together the medical marijuana community. Allowing not only patients and also local dispensaries for top level medicine in your community. BudTrader may be the largest online medical marijuana outpost, serving 30 states and Dc currently & expanding.
To read more about dabs check out our new website: click for info

###

Contact:
Brad Mclaughlin
[email protected]
2236 Encinitas Blvd, suite G
Encinitas, CA, 92024
Ph: 760-230-3188

Be First to Comment

Leave a Reply